Intellectual Property India Publishes Patent Application for 'Nkg2a Binding Agents And Uses Thereof' Filed by Exelixis, Inc.

MUMBAI, India, Oct. 11 -- Intellectual Property India has published a patent application (202517076880 A) filed by Exelixis, Inc., Alameda, U.S.A., on Aug. 12, for 'nkg2a binding agents and uses thereof.'

Inventor(s) include Hammer, Bonnie; Higaki, Jeffrey N.; Kantak, Seema; Li, Hanying; and Sim, Bee-Cheng.

The application for the patent was published on Oct. 10, under issue no. 41/2025.

According to the abstract released by the Intellectual Property India: "The present disclosure provides NKG2A binding agents (e.g, antibodies, including monospecific and multispecific antibodies such as bispecific antibodies) and uses thereof."

The patent application was internationally filed on Jan. 26, 2024, under International application No.PCT/US2024/013029.

Disclaimer: Curated by HT Syndication.